Dr Reddy's Laboratories Ltd. Reg. Shares (Sp.ADRs)/1 IR 5

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

12.20%

Market Cap

-

P/E Ratio

23.77

Dividend Yield

0.46 %

Earnings per Share

0.50 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE10.9 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 07:16:46 PM
DAILY VOLUME (UNITS)930
DAILY HIGH / LOW1110.8
PREV. DAY'S PRICE10.8 (07/20)
CHANGE DAY BEFORE
+0.10
0.93 %
52 WEEK HIGH / LOW13.6 (06/26)10.3 (05/12)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
0.750.750.500.450.58
DIVIDENDS PER SHARE
0.070.070.060.070.07
DIVIDEND YIELD IN %
0.55 %0.54 %0.46 %--
DIVIDEND GROWTH IN %
-5.41 %-10.63 %-16.77 %--
PRICE - EARNINGS RATIO
18.1416.4323.7724.4819.09
PRICE - BOOK RATIO
3.642.82---
PRICE - SALES RATIO
3.632.86---
PRICE - CASH FLOW RATIO
22.5220.08---
Further Key Figures

Master Data

WKN
659157
ISIN
US2561352038
SYMBOL
RDDA
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Dr. Reddys Labaratories ADR
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-4.42 %
-5.26 %
-1.82 %
-0.92 %
-12.20 %
-6.09 %
-10.00 %
-7.69 %
HIGH11.3013.6013.6013.6013.6015.4015.4013.60
LOW10.8010.8010.3010.3010.3010.308.7210.30

Dividende

pro Aktie

Company profile

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients, and Others. The Global Generics segment refers to the manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services and Active Ingredients segment focuses on manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.